Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Arthritis & Rheumatology (Hoboken, N.J.)|May 24, 2016
The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever RegistryNienke M Ter Haar, Jerold Jeyaratnam, Helen J Lachmann, et al.
Annals of the Rheumatic Diseases|November 1, 2017
Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform researchLiza J McCann, Clarissa A Pilkington, Adam M Huber, et al.
Annals of the Rheumatic Diseases|June 26, 2015
Recommendations for the management of autoinflammatory diseasesNienke M ter Haar, Marlen Oswald, Jerold Jeyaratnam, et al.
Clinical and Experimental Rheumatology|February 25, 2011
Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositisDinara Guseinova, Alessandro Consolaro, Lucia Trail, et al.
American Journal of Ophthalmology|September 10, 2017
Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case SeriesInge L Sarens, Ingele Casteels, Jordi Anton, et al.
Arthritis and Rheumatism|December 17, 2002
De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseasesIvona Aksentijevich, Miroslawa Nowak, Mustapha Mallah, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 3, 2018
IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic ArthritisVictoria L Arthur, Emily Shuldiner, Elaine F Remmers, et al.
Annals of the Rheumatic Diseases|April 13, 2018
Treating juvenile idiopathic arthritis to target: recommendations of an international task forceAngelo Ravelli, Alessandro Consolaro, Gerd Horneff, et al.
Annals of the Rheumatic Diseases|April 8, 2017
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeLisa G Rider, Rohit Aggarwal, Angela Pistorio, et al.
Arthritis Care & Research|March 2, 2010
Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patientsAngelo Ravelli, Lucia Trail, Cristina Ferrari, et al.
Pageof 6